Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to compete on price as it tries to claw back a larger share of the US market ...

Eli Lilly (LLY) is exiting CVS Health’s (CVS) drug benefit plan for its employees after the managed care giant decided to limit access to the company’s popular weight loss drug, Zepbound, in favor of ...

Speaking on the “Cheeky Pint” podcast, Ricks explained how list prices for Lilly’s insulin ballooned to $275, even as the company's actual net price remained around $40. He blamed a system where PBMs ...

President Donald Trump unveils a drug price discount chart last month in the Oval Office. (Shawn Thew/Pool/EPA/Shutterstock) In a landmark deal announced Thursday ...

Get ready to laugh, cry, and possibly text your therapist. "Mommy Issues" is a bold, hilarious, and heart-squeezing comedy variety show that dives headfirst into the whirlwind of modern motherhood.

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and ...

The interruption happened Thursday afternoon, Nov. 6 during an Oval Office event on efforts to reduce costs for weight-loss drugs. As Eli Lilly CEO David Ricks spoke, a man standing behind him ...